Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
July-2017 Volume 14 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2017 Volume 14 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Anti-rheumatic effects of Aconitum leucostomum Worosch. on human fibroblast-like synoviocyte rheumatoid arthritis cells

  • Authors:
    • Junling Yang
    • Feicui Zhao
    • Jihong Nie
  • View Affiliations / Copyright

    Affiliations: College of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi, Xinjiang 830011, P.R. China, Department of Pharmacy, Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi, Xinjiang 830000, P.R. China
  • Pages: 453-460
    |
    Published online on: May 23, 2017
       https://doi.org/10.3892/etm.2017.4503
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to investigate the effects of Aconitum leucostomum Worosch. crude drug, processed products and monomer components on human fibroblast‑like synoviocyte rheumatoid arthritis (HFLS‑RA) cells, and its associated mechanisms. Following drug treatment, cell proliferation was assessed using a Cell Counting Kit‑8 assay. Cellular apoptosis and cell cycle were evaluated using flow cytometry. Levels of hypoxia‑inducible factor 1α (HIF‑1α), vascular endothelial growth factor (VEGF) and toll‑like receptor 4 (TLR4) mRNA and protein were evaluated using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blot analysis, respectively. Levels of pro‑inflammatory cytokines were evaluated using ELISA. Analysis of cell proliferation indicated that crude drug and processed products markedly inhibited the cell proliferation. Compared with the control group, the apoptosis rates were significantly elevated in all treatment groups (all P<0.05). Furthermore, the proportion of cells in G0/G1 phase was significantly decreased in all treatment groups compared with the control group (all P<0.05). RT‑qPCR and western blotting indicated that, compared with the control group, mRNA and protein expression levels of HIF‑1α, and TLR4 were significantly downregulated in all treatment groups (P<0.05). The mRNA and protein expression levels of VEGF in all treatment groups were decreased compared with those in the control group, but the difference was not significant. Results from ELISA demonstrated that the levels of interleukin (IL)‑6, IL‑1β and tumor necrosis factor‑α in the cell culture supernatant were all significantly decreased following drug treatment in HFLS‑RA cells (all P<0.05). Therefore, A. leucostomum Worosch. crude drug, processed products and monomer components may exert anti‑rheumatic effects on HFLS-RA cells, inhibiting cell proliferation and enhancing cellular apoptosis. These effects may be attributable to the downregulated expression of HIF‑1α and TLR4, as well as decreased levels of pro‑inflammatory cytokines.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Seyler TM, Park YW, Takemura S, Bram RJ, Kurtin PJ, Goronzy JJ and Weyand CM: BLyS and APRIL in rheumatoid arthritis. J Clin Invest. 115:3083–3092. 2005. View Article : Google Scholar : PubMed/NCBI

2 

Yamaannishi Y and Firestein GS: Pathogenesis of rheumatoid arthritis: The role of synoviocytes. Rheum Dis Clin North Am. 27:355–371. 2001. View Article : Google Scholar : PubMed/NCBI

3 

Wang JB and Pan L: Etiology and pathogenesis of rheumatoid arthritis. Shandong Yi Yao Za Zhi. 42:69–70. 2002.

4 

Perlman H, Pagliari LJ, Liu H, Koch AE, Haines GK III and Pope RM: Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis Rheum. 44:21–30. 2001. View Article : Google Scholar : PubMed/NCBI

5 

Sivakumar B, Akhavani MA, Winlove CP, Taylor PC, Paleolog EM and Kang N: Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis. J Hand Surg Am. 33:49–58. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Konisti S, Kiriakidis S and Paleolog EM: Hypoxia-a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol. 8:153–162. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Huang X, Chen Y and Gong L: Measurement of serum hypoxia inducible factor-1α in patients with rheumatoid arthritis and the correlation with ultrasonographic assessment of synovial lesions. Zhejiang Med J. 33:1420–1422. 2011.

8 

Del Rey MJ, Izquierdo E, Usategui A, Gonzalo E, Blanco FJ, Acquadro F and Pablos JL: The transcriptional response of normal and rheumatoid arthritis synovial fibroblasts to hypoxia. Arthritis Rheum. 62:3584–3594. 2010. View Article : Google Scholar : PubMed/NCBI

9 

You P, Lin M, Li K, Ye X and Zheng J: Normobaric oxygen therapy inhibits HIF-1α and VEGF expression in perihematoma and reduces neurological function defects. Neuroreport. 27:329–336. 2016.PubMed/NCBI

10 

Cheng S, He C, Zhou H, Kong X, Xie H, Xia L and Yan J: The effect of Toll-like receptor 4 on β2-glycoprotein I-induced B cell activation in mouse model. Mol Immunol. 71:78–86. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Huang B, Wang QT, Liu KK, Jiang L and Wei W: The relationship between TNF-α signaling pathway and CD4 + T cells in the development of rheumatoid arthritis. Zhong Guo Yao Li Xue Tong Bao. 29:900–903. 2013.

12 

Xiao JY, Wang BS and Wang SJ: Expression of IL-1 and TNF-α in adjuvant arthritis rat models. J Emer Trad Chin Med. 20:607–608. 2011.

13 

Manfredi AA, Baldini M, Camera M, Baldissera E, Brambilla M, Peretti G, Maseri A, Rovere-Querini P, Tremoli E, Sabbadini MG and Maugeri N: Anti-TNFα agents curb platelet activation in patients with rheumatoid arthritis. Ann Rheum Dis. 75:1511–1520. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Cacciapaglia F, Anelli MG, Rizzo D, Morelli E, Scioscia C, Mazzotta D, Iannone F and Lapadula G: Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients. Reumatismo. 67:97–102. 2015. View Article : Google Scholar : PubMed/NCBI

15 

Wang XK, Li B, Ren Y, Liang ZC and Yang ZB: Effects of Alcohol Extract of toddalia asiatica on the Inflammation-associated cytokines of model rats with Adjuvant arthritis. Zhong Guo Yao Fang. 27:3524–3527. 2016.

16 

Editorial Committee of Flora of China, China Academy of Sciences: Flora of China. 27. Chinese Science Publishing and Media Ltd.; Beijing: pp. 113–326. 1979

17 

Xin Xu: Bahaerguli Huangerhan. Kazakh Pharmacopeia. 1. Ethnic Publishing House; Beijing: pp. 45–47. 2009

18 

Meng Q, Liang J and Wu G: Advances in pharmacological effects of alkaloids. Lishizhen Med Materia Med Res. 14:700–702. 2003.

19 

Xinjiang Institute of Biological Soil Desert, . Xinjiang Medicinal Flora. 1. Xinjiang People's Publishing House; Urumqi: 1977

20 

Editorial Committee of Flora of Xinjiang, . Flora of Xinjiang. 1. Xinjiang Science and Technology Health Press; Urumqi: 1999

21 

Yang JL, Lu J, Liu J and Nie JH: Effects of Diphtheria Aconitum and processed products on adjuvant-induced arthritis rat model. Chinese Medicine. 37:2495–2501. 2015.

22 

Wang F, Zhao J, Zhao F and Nie J: Study on the chemical constituents of Aconitum leucostomum Worosch. China Pharmacy. 26:1233–1235. 2015.

23 

Wu M and Wei Y: Ethnobotany of Aconitum in Xinjiang. Chinese Wild Plant Resources. 23:29–30. 2004.(In Chinese).

24 

Editorial Committee of Chinese Pharmacopoeia, . Chinese Pharmacopoeia. 1. Chinese Medical Science and Technology Press; Beijing: pp. 33–34. 2010

25 

Wiacek R, Kolossa K, Jankowski T, Jeka S, Karmowski A, Karmowski M and Gworys B: The efficacy and safety of leflunomide in patients with active rheumatoid arthritis. Adv Clin Exp Med. 21:337–342. 2012.PubMed/NCBI

26 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

27 

Chen L, Wang WS, Wang YM and Shi CH: The expression of VEGF and TGF-β1 in synovial membrane of the patients of Knee joint pannus. Shi He Zi Da Xue Xue Bao (Zi Ran Ke Xue Ban). 28:72–75. 2010.

28 

Shiozawa S, Tsumiyama K, Yoshida K and Hashiramoto A: Pathogenesis of joint destruction in rheumatoid arthritis. Arch Immunol Ther Exp (Warsz). 59:89–95. 2011. View Article : Google Scholar : PubMed/NCBI

29 

Brouwer E, Gouw AS, Posthumus MD, van Leeuwen MA, Boerboom AL, Bijzet J, Bos R, Limburg PC, Kallenberg CG and Westra J: Hypoxia inducible factor-1-alpha (HIF-1alpha) is related to both angiogenesis and inflammation in rheumatoid arthritis. Clin Exp Rheumatol. 27:945–951. 2009.PubMed/NCBI

30 

Shankar J, Thippegowda PB and Kanum SA: Inhibition of HIF-1alpha activity by BP-1 ameliorates adjuvant induced arthritis in rats. Biochem Biophys Res Commun. 387:223–228. 2009. View Article : Google Scholar : PubMed/NCBI

31 

Huang XQ, Chen Y, Chen LB, Gong LM, Xie BH, Peng Y, Huang H, Xin XF, Wu XD and Zhang Z: Measurement of serum vascular endothelial growth factor, angiopoietin-1 and angiopoietin-2 in patients with rheumatoid arthritis and the correlation with synovial lesions. Chin J Rheumatol. 16:679–683. 2012.(In Chinese).

32 

Migita K, Miyashita T, Maeda Y, Nakamura M, Yatsuhashi H, Kimura H, Ishibashi H and Eguchi K: Toll-like receptor expression in lupus peripheral blood mononuclear cells. J Rheumatol. 34:493–500. 2007.PubMed/NCBI

33 

Ning X and Lu ZJ: Expression of Fibrosis-related Cytokine in Budd-Chiari Syndrome. Chin Gen Prac. 18:2026–2029. 2015.

34 

Chou LW, Wang J, Chang PL and Hsieh YL: Hyaluronan modulates accumulation of hypoxiainducible factor-1 alpha, inducible nitric oxide synthase, and matrix metalloproteinase-3 in the synovium of rat adjuvant-induced arthritis model. Arthritis Res Ther. 13:R902011. View Article : Google Scholar : PubMed/NCBI

35 

Westra J, Brouwer E, van Roosmalen IA, Doornbos-van der Meer B, van Leeuwen MA, Posthumus MD and Kallenberg CG: Expression and regulation of HIF-1alpha in macrophages under inflammatory conditions; significant reduction of VEGF by CaMKII inhibitor. BMC Musculoskelet Disord. 11:612010. View Article : Google Scholar : PubMed/NCBI

36 

Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al: 2010 Rheumatoid arthritis classification criteria: An American college of rheumatology/european league against rheumatism collaborative initiative. Arthritis Rheum. 62:2569–2581. 2010. View Article : Google Scholar : PubMed/NCBI

37 

Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, Moskowitz RW and Schnitzer TJ: Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum. 38:1541–1546. 1995. View Article : Google Scholar : PubMed/NCBI

38 

Cramer T, Yamanishi Y, Clausen BE, Förster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, et al: HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell. 112:645–657. 2003. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yang J, Zhao F and Nie J: Anti-rheumatic effects of Aconitum leucostomum Worosch. on human fibroblast-like synoviocyte rheumatoid arthritis cells. Exp Ther Med 14: 453-460, 2017.
APA
Yang, J., Zhao, F., & Nie, J. (2017). Anti-rheumatic effects of Aconitum leucostomum Worosch. on human fibroblast-like synoviocyte rheumatoid arthritis cells. Experimental and Therapeutic Medicine, 14, 453-460. https://doi.org/10.3892/etm.2017.4503
MLA
Yang, J., Zhao, F., Nie, J."Anti-rheumatic effects of Aconitum leucostomum Worosch. on human fibroblast-like synoviocyte rheumatoid arthritis cells". Experimental and Therapeutic Medicine 14.1 (2017): 453-460.
Chicago
Yang, J., Zhao, F., Nie, J."Anti-rheumatic effects of Aconitum leucostomum Worosch. on human fibroblast-like synoviocyte rheumatoid arthritis cells". Experimental and Therapeutic Medicine 14, no. 1 (2017): 453-460. https://doi.org/10.3892/etm.2017.4503
Copy and paste a formatted citation
x
Spandidos Publications style
Yang J, Zhao F and Nie J: Anti-rheumatic effects of Aconitum leucostomum Worosch. on human fibroblast-like synoviocyte rheumatoid arthritis cells. Exp Ther Med 14: 453-460, 2017.
APA
Yang, J., Zhao, F., & Nie, J. (2017). Anti-rheumatic effects of Aconitum leucostomum Worosch. on human fibroblast-like synoviocyte rheumatoid arthritis cells. Experimental and Therapeutic Medicine, 14, 453-460. https://doi.org/10.3892/etm.2017.4503
MLA
Yang, J., Zhao, F., Nie, J."Anti-rheumatic effects of Aconitum leucostomum Worosch. on human fibroblast-like synoviocyte rheumatoid arthritis cells". Experimental and Therapeutic Medicine 14.1 (2017): 453-460.
Chicago
Yang, J., Zhao, F., Nie, J."Anti-rheumatic effects of Aconitum leucostomum Worosch. on human fibroblast-like synoviocyte rheumatoid arthritis cells". Experimental and Therapeutic Medicine 14, no. 1 (2017): 453-460. https://doi.org/10.3892/etm.2017.4503
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team